| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.89▼ | 1.90▼ | 1.91▼ | 1.83▲ | 2.00▼ |
| MA10 | 1.89▲ | 1.92▼ | 1.89▲ | 1.85▲ | 2.07▼ |
| MA20 | 1.89▼ | 1.88▲ | 1.86▲ | 1.97▼ | 2.26▼ |
| MA50 | 1.92▼ | 1.85▲ | 1.83▲ | 2.14▼ | 2.07▼ |
| MA100 | 1.88▲ | 1.83▲ | 1.90▼ | 2.26▼ | 3.68▼ |
| MA200 | 1.85▲ | 1.92▼ | 2.02▼ | 2.14▼ | 4.81▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.004▼ | 0.006▲ | -0.002▼ | -0.054▼ |
| RSI | 43.774▼ | 52.803▲ | 55.345▲ | 44.619▼ | 42.216▼ |
| STOCH | 48.333 | 31.964 | 72.491 | 38.400 | 22.829 |
| WILL %R | -60.000 | -46.875 | -41.667 | -56.153 | -82.616▼ |
| CCI | 1.905 | -41.067 | 36.409 | 5.229 | -104.837▼ |
|
Wednesday, February 11, 2026 08:03 PM
C4 Therapeutics (NASDAQ:CCCC) executives outlined plans to advance their lead multiple myeloma program and expand the company’s broader targeted protein degradation (TPD) platform during a fireside ...
|
|
Wednesday, February 04, 2026 04:28 AM
A live webcast will be available on the Investors section of the company’s website at www.c4therapeutics.com. An archived replay of the webcast will be available for approximately 90 days following ...
|
|
Monday, January 26, 2026 01:16 PM
C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 1.85 | 1.97 | 1.85 | 1.89 | 697,900 |
| 12/02/26 | 1.80 | 1.865 | 1.7814 | 1.83 | 621,961 |
| 11/02/26 | 1.85 | 1.882 | 1.735 | 1.83 | 1,100,900 |
| 10/02/26 | 1.78 | 1.90 | 1.78 | 1.84 | 676,579 |
| 09/02/26 | 1.82 | 1.82 | 1.75 | 1.78 | 575,000 |
| 06/02/26 | 1.77 | 1.8686 | 1.725 | 1.82 | 821,298 |
| 05/02/26 | 1.88 | 1.91 | 1.6901 | 1.71 | 846,959 |
| 04/02/26 | 2.01 | 2.01 | 1.805 | 1.89 | 1,119,986 |
| 03/02/26 | 1.88 | 2.035 | 1.88 | 2.01 | 1,388,713 |
| 02/02/26 | 1.90 | 1.93 | 1.85 | 1.88 | 850,914 |
|
|
||||
|
|
||||
|
|